JENNIFER RUTLEDGE: Open Payments
NPI 1932599487 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 17 payments from 8 companies in 2025. Trend: 2023 $339 · 2024 $566 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $171 |
| Novo Nordisk Inc | 6 | $128 |
| Exact Sciences Corporation | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, Wegovy, The Cologuard Plus Collection Kit, BREZTRI, Rybelsus, Ozempic, JARDIANCE, GARDASIL 9.
Industry payments across NC — which companies pay providers there.
